Ticker
JANXCompany Name
JANUX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -59.79M | -13620.27% | $ 439K |
3/31/2025 | $ -46M | -492.73% | $ 9.34M |
12/31/2024 | $ -43.81M | -413.81% | $ 10.59M |
9/30/2024 | $ -36.99M | -283.47% | $ 13.05M |
6/30/2024 | $ -46.47M | -307.19% | $ 15.13M |
3/31/2024 | $ -51.5M | -706.75% | $ 7.29M |
12/31/2023 | $ -50.58M | -625.7% | $ 8.08M |
9/30/2023 | $ -52.59M | -621.08% | $ 8.47M |
6/30/2023 | $ -54.29M | -699.37% | $ 7.76M |
3/31/2023 | $ -45.31M | -499.51% | $ 9.07M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for JANUX THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -16.98M ] / Revenues [ $ 3.64M ]
(=) OCF % [ -466.76% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 77.08% |
average | 14.31% |
median | 12.65% |
std | 21.13% |